Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
Clinical trial NCT03213145 · COMPLETED
Trial details
- NCT number
- NCT03213145
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2017-08-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.